JP5276002B2 - 肝疾患の治療 - Google Patents

肝疾患の治療 Download PDF

Info

Publication number
JP5276002B2
JP5276002B2 JP2009533950A JP2009533950A JP5276002B2 JP 5276002 B2 JP5276002 B2 JP 5276002B2 JP 2009533950 A JP2009533950 A JP 2009533950A JP 2009533950 A JP2009533950 A JP 2009533950A JP 5276002 B2 JP5276002 B2 JP 5276002B2
Authority
JP
Japan
Prior art keywords
albumin
blood
individual
endotoxin
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009533950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010507432A (ja
JP2010507432A5 (enExample
Inventor
デビース，ネイサン
ジャラン，ラジブ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Biomedica PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Biomedica PLC filed Critical UCL Biomedica PLC
Publication of JP2010507432A publication Critical patent/JP2010507432A/ja
Publication of JP2010507432A5 publication Critical patent/JP2010507432A5/ja
Application granted granted Critical
Publication of JP5276002B2 publication Critical patent/JP5276002B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2009533950A 2006-10-27 2007-10-29 肝疾患の治療 Active JP5276002B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0621452.2 2006-10-27
GBGB0621452.2A GB0621452D0 (en) 2006-10-27 2006-10-27 Therapy for liver disease
PCT/GB2007/004126 WO2008050148A2 (en) 2006-10-27 2007-10-29 Therapy for liver disease

Publications (3)

Publication Number Publication Date
JP2010507432A JP2010507432A (ja) 2010-03-11
JP2010507432A5 JP2010507432A5 (enExample) 2010-12-09
JP5276002B2 true JP5276002B2 (ja) 2013-08-28

Family

ID=37546125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533950A Active JP5276002B2 (ja) 2006-10-27 2007-10-29 肝疾患の治療

Country Status (8)

Country Link
US (1) US8480607B2 (enExample)
EP (1) EP2061533B1 (enExample)
JP (1) JP5276002B2 (enExample)
CN (1) CN101541357B (enExample)
DK (1) DK2061533T3 (enExample)
ES (1) ES2843374T3 (enExample)
GB (1) GB0621452D0 (enExample)
WO (1) WO2008050148A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009216769A1 (en) * 2008-02-20 2009-08-27 Novartis Ag Heterocyclic inhibitors of stearoyl-CoA desaturase
WO2013028809A2 (en) 2011-08-22 2013-02-28 Medtronic, Inc. Dual flow sorbent cartridge
US10624924B2 (en) 2012-03-12 2020-04-21 Grifols, S.A. Method and device for treating blood cholesterol disorders
US11154648B2 (en) 2013-01-09 2021-10-26 Medtronic, Inc. Fluid circuits for sorbent cartridge with sensors
US9713666B2 (en) 2013-01-09 2017-07-25 Medtronic, Inc. Recirculating dialysate fluid circuit for blood measurement
US9144640B2 (en) 2013-02-02 2015-09-29 Medtronic, Inc. Sorbent cartridge configurations for improved dialysate regeneration
US9943780B2 (en) 2013-11-26 2018-04-17 Medtronic, Inc. Module for in-line recharging of sorbent materials with optional bypass
US9884145B2 (en) 2013-11-26 2018-02-06 Medtronic, Inc. Parallel modules for in-line recharging of sorbents using alternate duty cycles
US10537875B2 (en) 2013-11-26 2020-01-21 Medtronic, Inc. Precision recharging of sorbent materials using patient and session data
US9895477B2 (en) 2013-11-26 2018-02-20 Medtronic, Inc. Detachable module for recharging sorbent materials with optional bypass
US10052612B2 (en) 2013-11-26 2018-08-21 Medtronic, Inc. Zirconium phosphate recharging method and apparatus
US10004839B2 (en) 2013-11-26 2018-06-26 Medtronic, Inc. Multi-use sorbent cartridge
RU2539139C1 (ru) * 2014-02-13 2015-01-10 Артем Сергеевич Арапов Способ лечения отека мозга у больных хроническими заболеваниями печени
AU2015201496B2 (en) 2014-06-03 2019-10-31 Grifols Worldwide Operations Limited Use of plasmapheresis to treat blood pressure disorders
US20170092985A1 (en) * 2014-06-05 2017-03-30 Sony Corporation Secondary battery-use electrolytic solution, secondary battery, battery pack, electric vehicle, electric power storage system, electric power tool, and electronic apparatus
EP3160531B1 (en) 2014-06-24 2019-08-14 Medtronic Inc. Replenisihing urease in dialysis systems using a urease introducer
EP3160532B1 (en) 2014-06-24 2019-09-18 Medtronic Inc. A urease introduction system for replenishing urease in a sorbent cartridge
US10286380B2 (en) 2014-06-24 2019-05-14 Medtronic, Inc. Sorbent pouch
US10357757B2 (en) 2014-06-24 2019-07-23 Medtronic, Inc. Stacked sorbent assembly
EP3160529B1 (en) 2014-06-24 2019-11-13 Medtronic Inc. Replenishing urease in dialysis systems using urease pouches
WO2015199766A1 (en) 2014-06-24 2015-12-30 Medtronic, Inc. Modular dialysate regeneration assembly
WO2016145211A1 (en) 2015-03-10 2016-09-15 Life Warmer Inc. Thermic infusion system
US10981148B2 (en) 2016-11-29 2021-04-20 Medtronic, Inc. Zirconium oxide module conditioning
US11167070B2 (en) 2017-01-30 2021-11-09 Medtronic, Inc. Ganged modular recharging system
US10960381B2 (en) 2017-06-15 2021-03-30 Medtronic, Inc. Zirconium phosphate disinfection recharging and conditioning
US11707580B2 (en) 2017-09-08 2023-07-25 Life Warmer Inc. Thermic infusion system dry tube detector
US12285552B2 (en) 2018-08-14 2025-04-29 Mozarc Medical Us Llc Precision dialysis therapy based on sorbent effluent analysis
US11213616B2 (en) 2018-08-24 2022-01-04 Medtronic, Inc. Recharge solution for zirconium phosphate
WO2020120801A1 (en) * 2018-12-14 2020-06-18 Bia Separations D.O.O. A method for depletion or removal of endotoxin from an endotoxin-containing source or potentially endotoxin-containing source
WO2020216437A1 (en) * 2019-04-23 2020-10-29 Espire Technologies Gmbh Device and method for localising or identifying malignancies
EP3786642A1 (en) * 2019-08-30 2021-03-03 ESPIRE Technologies GmbH Method for functional characteristics of proteins for classification of patients to be associated to a specific disease
GB202004775D0 (en) * 2020-03-31 2020-05-13 Ucl Business Ltd Apparatus
US12397093B2 (en) 2021-05-18 2025-08-26 Mozarc Medical Us Llc Sorbent cartridge designs
GB202307837D0 (en) 2023-05-25 2023-07-12 Yaqrit Ltd Dialysis method
WO2024254494A2 (en) * 2023-06-09 2024-12-12 Kanzo Biomedicines, Inc. Liver support systems and methods of use

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093612A (en) * 1975-08-04 1978-06-06 Research Corporation Selective removal of albumin from blood fluids and compositions therefore
JPS5670028A (en) 1979-11-12 1981-06-11 Teijin Ltd Polymer bonding with albumin
US4476715A (en) * 1983-03-11 1984-10-16 Murphy Jack L Mud metering tank monitoring system
JPH0738880B2 (ja) 1983-06-24 1995-05-01 東レ株式会社 エンドトキシン血症治療剤
US5179018A (en) 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
US5476715A (en) * 1989-10-03 1995-12-19 Fresenius Ag Particulate adsorbent for the removal of biomacromolecules such as LDL and endotoxins from whole blood in extracorporeal circuits
DE4309410A1 (de) * 1993-03-19 1995-02-16 Stange Jan Material, Verfahren und Einrichtung zur selektiven Trennung frei gelöster und stoffgebundener Stoffe aus flüssigen Stoffgemischen sowie Verfahren zur Herstellung des Materials
JP3413985B2 (ja) 1994-09-29 2003-06-09 東レ株式会社 選択分離膜およびそれを用いた血液処理装置
DE4435612A1 (de) * 1994-10-05 1996-04-11 Braun Melsungen Ag Verfahren zur simultanen Entfernung von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus einer wäßrigen Flüssigkeit
IT1279209B1 (it) 1995-05-16 1997-12-04 Bellco Spa Filtro dializzatore/reattore atto ad effettuare la cattura di endotossine, e procedimento per la sua realizzazione.
JPH1071201A (ja) * 1996-01-19 1998-03-17 Terumo Corp 血液浄化排液再生装置、血液浄化液回路および血液浄化装置
JPH11137672A (ja) * 1997-11-05 1999-05-25 Asa Sangyo Kk 腹膜透析液回収・再生方法及び装置
JPH11225725A (ja) * 1998-02-16 1999-08-24 Yoshinori Naito 冷凍食品および冷凍食品の製造方法
EP1063289A1 (en) 1998-03-03 2000-12-27 JMS Co., Ltd. Liver cell clones for artifical liver and extracorporeal liver assist device
JPH11225752A (ja) 1998-02-16 1999-08-24 Jms Co Ltd 人工肝臓用肝細胞クローンおよび体外循環肝補助装置
JP2000107286A (ja) * 1998-10-07 2000-04-18 Akira Sakai 腹膜透析液の灌流装置及び灌流法
US8026096B1 (en) * 1998-10-08 2011-09-27 Protein Sciences Corporation In vivo active erythropoietin produced in insect cells
US6774102B1 (en) * 1999-09-29 2004-08-10 Gambro Dialysatoren Gmbh & Co. Kg Extracorporeal endotoxin removal method
US6365147B1 (en) * 1999-10-13 2002-04-02 New Jersey Institute Of Technology Methods for removing endotoxins from biological solutions using immobilized metal affinity chromatography
US6787040B2 (en) * 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
JP2003135594A (ja) * 2001-10-30 2003-05-13 Toray Medical Co Ltd 体液浄化カラム
SE522692C2 (sv) * 2002-03-27 2004-03-02 Gambro Lundia Ab Förfarande och anordning för avlägsnande av delvis proteinbundna substanser
JP4201313B2 (ja) 2002-04-11 2008-12-24 旭化成クラレメディカル株式会社 有害物質結合アルブミン除去システム
JP2003310752A (ja) 2002-04-25 2003-11-05 Toray Ind Inc 生理活性物質固定化成型品の製造方法
SE526038C2 (sv) 2002-07-08 2005-06-21 Gambro Lundia Ab Polymeraffinitetsmatris, förfarande för framställning därav och anvädning därav
JP2004121445A (ja) * 2002-10-01 2004-04-22 Akira Sakai 酸化ストレス消去材、それを有する透析液循環回路及び酸化ストレス消去法
CA2514981A1 (en) * 2003-03-12 2004-09-23 Fresenius Kabi Deutschland Gmbh Use of recombinant albumin in dialysis after liver failure
WO2004082737A2 (en) * 2003-03-17 2004-09-30 Hemavation Llc Extracorporeal blood treatment device for removing blood toxins, and methods thereof
JP4352775B2 (ja) * 2003-06-19 2009-10-28 株式会社ジェイ・エム・エス 血液透析濾過装置
US20050037331A1 (en) * 2003-08-13 2005-02-17 William Galbraith Apparatuses and methods for reducing albumin in samples
CN2810611Y (zh) * 2005-06-22 2006-08-30 浙江科锐生物科技有限公司 一种体外人工肝支持系统
US20080031874A1 (en) * 2006-02-06 2008-02-07 Sanders Martin E Treatment of endotoxemia using endotoxin neutralizing agents

Also Published As

Publication number Publication date
GB0621452D0 (en) 2006-12-06
EP2061533B1 (en) 2020-11-25
CN101541357A (zh) 2009-09-23
JP2010507432A (ja) 2010-03-11
CN101541357B (zh) 2012-07-04
US20100025328A1 (en) 2010-02-04
WO2008050148A3 (en) 2008-07-17
EP2061533A2 (en) 2009-05-27
WO2008050148A2 (en) 2008-05-02
ES2843374T3 (es) 2021-07-16
US8480607B2 (en) 2013-07-09
DK2061533T3 (da) 2020-12-21

Similar Documents

Publication Publication Date Title
JP5276002B2 (ja) 肝疾患の治療
Heemann et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study
Davis et al. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I
Atcheson et al. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant
Lerolle et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration
Zimmerman et al. Goodpasture's syndrome with normal renal function
Karoli et al. Predictors of diabetic retinopathy in patients with type 2 diabetes who have normoalbuminuria
Schenk et al. Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb
Honda et al. De novo membranous nephropathy and antibody‐mediated rejection in transplanted kidney
MX2009002378A (es) Biomarcadores para evaluar la funcion hepatica.
CN116096441A (zh) 体外除去血液中白蛋白和内毒素的仪器
Kimura et al. Lenalidomide as a beneficial treatment option for renal impairment caused by light chain deposition disease
Bell et al. Antibasement Membrane Antibody Disease without Clinical Evidence of Renal Disease1. 2
Kusaba et al. Significance of broad distribution of electron-dense deposits in patients with IgA nephropathy
US8415117B2 (en) Prognosis and therapy of liver failure
WO2014120642A1 (en) Diagnosis and treatment of hepatorenal syndrome
Kalowski et al. Multinucleated giant cells in antiglomerular basement membrane antibody-induced glomerulonephritis
WO2024241060A1 (en) Dialysis method
Czarnecka et al. Real-life comparison of efficacy and safety profiles of two prolonged-release tacrolimus formulations in de novo kidney transplant recipients: 24 months of follow-up
Jung et al. Anti-glomerular basement membrane disease associated with thin basement membrane nephropathy: a case report
Gollasch Insights in Nephrology: 2021
Tillmann Daily postdilutional hemodiafiltration with FX800 polysulfone dialyzers for removing kappa light chains in multiple myeloma-induced kidney injury
Cardoso Fernandes et al. New Onset Nephrotic-Range Proteinuria in a Patient with Chronic Kidney Disease-Not Always What it Seems
Rai et al. Renal amyloidosis causing nephrotic syndrome: An unusual presentation of light chain myeloma
Trajceska et al. SP099 COMPLICATIONS AND RISKS OF PERCUTANEOUS RENAL BIOPSY

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101021

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120904

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121128

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130301

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130416

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130516

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5276002

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250